Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Dividends Paid - Common (2016 - 2025)

Phibro Animal Health (PAHC) has 12 years of Dividends Paid - Common data on record, last reported at $4.9 million in Q4 2025.

  • For Q4 2025, Dividends Paid - Common changed 0.08% year-over-year to $4.9 million; the TTM value through Dec 2025 reached $19.5 million, changed 0.08%, while the annual FY2025 figure was $19.4 million, 0.04% changed from the prior year.
  • Dividends Paid - Common reached $4.9 million in Q4 2025 per PAHC's latest filing, roughly flat from $4.9 million in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $4.9 million in Q1 2025 and bottomed at $4.9 million in Q1 2021.
  • Average Dividends Paid - Common over 5 years is $4.9 million, with a median of $4.9 million recorded in 2021.
  • Peak YoY movement for Dividends Paid - Common: increased 0.12% in 2021, then decreased 0.02% in 2022.
  • A 5-year view of Dividends Paid - Common shows it stood at $4.9 million in 2021, then fell by 0.02% to $4.9 million in 2022, then increased by 0.02% to $4.9 million in 2023, then fell by 0.02% to $4.9 million in 2024, then grew by 0.08% to $4.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Dividends Paid - Common were $4.9 million in Q4 2025, $4.9 million in Q3 2025, and $4.9 million in Q2 2025.